Transurethral Electrovaporization of the Prostate(tvp) with Vaportoom

王行环,罗耀雄,冯自卫,杨浣情,刘久敏,古维灿,罗则民

DOI: https://doi.org/10.3969/j.issn.1005-6483.2001.03.015

2001-01-01

Abstract:Objectives Transurethral resection of the prostate(TURP) is still considered the ‘Gold standard’ in the treatment of BPH, although it causes some morbidity such as bleeding, TUR-syndrome. Transurethral electrovaporization of the prostate (TVP) is a new, minimally invasive and promising alternative to standard TURP in the treatment of BPH. This study is aimed to evaluate the effect and safety of TVP for the symptomatic BPH.Methods TVP was carried out using an standard irrigating resectoscope with vaportoom (Circon Acmi). Irrigating fluids is 5% glucose solution.Over a 18 month period,300 consecutive men (mean age 71.5 years, range 54-88) with symptomatic BPH (mean prostate volume 47.3±35.6 g, range 20-138) fulfilled the conventional criteria for a prostatectomy were treated with TVP.Preoperative and postoperative International Prostate Symptom Score (IPSS),Quality of Life(QOL),Maximum flow rates (PFR) and complications were recorded in each patient.Results The PFR increased from 4.4 to 18.6, 21.7, and 21.5 ml/s at 1,3,and 6 months, respectively. IPSS decreased from 25.5 to 5.1,5.0,and 3.2 at 1,3,and 6 months, respectively. Mean operative duration is 35 min (range 15-105). None of the patients required a blood transfusion. TUR-syndrome and sphincteric incontinence were not found. Catheters removed in 24-96 h following surgery.19/300 patients experienced retention and need 2-5 days recatheterization. 60/78(77%) patients had retrograde ejaculation.Conclusions TVP is an effective alternative in the treatment of symptomatic BPH, with the advantages of minimal bleeding, no need for blood transfusion and no TUR-Syndrome.